Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?

Totzeck Matthias; Lutgens Esther; Neilan Tomas G.

首页> 外文期刊>European Heart Journal: The Journal of the European Society of Cardiology >Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?

【24h】

Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?

机译：我们是否低估了与免疫检查点抑制剂相关的心脏毒性的可能性？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Heart Journal: The Journal of the European Society of Cardiology》 |2021年第16期|共4页
作者
Totzeck Matthias; Lutgens Esther; Neilan Tomas G.;
展开▼
作者单位

Univ Hosp Essen Fac Med West German Heart &

Vasc Ctr Dept Cardiol &

Vasc Med Essen Germany;

Univ Amsterdam Dept Med Biochem Amsterdam Univ Med Ctr Expt Vasc Biol Div Amsterdam Cardiovasc;

Massachusetts Gen Hosp Div Cardiol Cardiovasc Imaging Res Ctr Boston MA 02114 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Managing cardiotoxicity associated with immune checkpoint inhibitors [J] . Sireesha Upadhrasta1, Hadi Elias1, Keval Patel2, 慢性疾病与转化医学：英文版 . 2019,第001期
2. Managing cardiotoxicity associated with immune checkpoint inhibitors [J] . Sireesha Upadhrasta, Hadi Elias, Keval Patel, 慢性疾病与转化医学（英文） . 2019,第001期
3. Cancer immune checkpoint blockade therapy and its associated autoimmune cardiotoxicity [J] . Jiu-cheng Zhang, Wei-dong Chen, Jean Bustamante Alvarez, 中国药理学报：英文版 . 2018,第011期
4. Precision Cardio-Oncology: a Systems-Based Perspective on Cardiotoxicity of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors [J] . Sherry-Ann Brown, Jordan C. Ray, Joerg Herrmann Journal of cardiovascular translational research . 2020,第3期

机译：精确的心肌肿瘤：基于系统的酪氨酸激酶抑制剂和免疫检查点抑制剂的心脏毒性的视角
5. Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure [J] . Waliany Sarah, Lee Daniel, Witteles Ronald M., Annual Review of Pharmacology and Toxicology . 2021,第1期

机译：免疫检查点抑制剂心脏毒性：了解基本机制和临床特征，并寻找治疗方法
6. Original Research Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials [J] . Agostinetto Elisa, Eiger Daniel, Lambertini Matteo, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2021,第1期

机译：免疫检查点抑制剂的原始研究心脏毒性：随机临床试验的系统评价和荟萃分析
7. ENGINEERING AND PRE-CLINICAL EVALUATION OF A HUMAN ENZYME IMMUNE CHECKPOINT INHIBITOR FOR CANCER THERAPY [C] . Everett Stone, John Blazek, Christos Karamitros, Enzyme Engineering Conference . 2018

机译：癌症治疗人酶免疫检查点抑制剂的工程与临床评价
8. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
9. Immune Checkpoint Inhibitors: Cardiotoxicity in Pre-clinical Models and Clinical Studies [O] . Shirley Xu, Umesh C. Sharma, Cheyanna Tuttle, 2021

机译：免疫检查点抑制剂：在临床前模型和临床研究中的心脏毒性
10. Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors? [O] . Matthias Totzeck, Esther Lutgens, Tomas G Neilan 2020

机译：我们是否低估了与免疫检查点抑制剂相关的心脏毒性的可能性？
11. Phase 1 Trial of an Immune Checkpoint Inhibitor plus Stereotactic Ablative Radiotherapy in Patients with Inoperable Stage I Non-Small Cell Lung Cancer. [R] . Kelly, K., Monjazeb, A., Daly, M., 2017

机译：免疫检查点抑制剂加立体定向消融放疗治疗不能手术的I期非小细胞肺癌的1期试验。

Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?

著录项

相似文献

相关主题

期刊订阅